乳腺MRI标准方案对排除高位或晚期腋窝淋巴结转移的价值:ACOSOG Z0011试验后时代
该回顾性研究纳入435例浸润性乳腺癌女性,比较标准MRI(含低位腋窝)与联合MRI(含全腋窝)对高位或晚期腋窝淋巴结转移的检测效能。标准MRI上,瘤周水肿和腋窝阳性是高位/晚期转移的预测因子;无瘤周水肿且腋窝阴性者中仅少数存在高位或晚期转移。结论认为标准MRI对多数患者排除高位或晚期转移表现满意,但存在瘤周水肿或腋窝阳性时联合MRI方案有额外获益。
要点
- 标准MRI上瘤周水肿和腋窝阳性是高位或晚期腋窝淋巴结转移的预测因子。
- 无瘤周水肿且腋窝阴性的患者中,高位或晚期腋窝转移发生率低。
- 存在瘤周水肿或腋窝阳性时,建议加扫全腋窝联合MRI方案。
关键影像表现/征象
- 标准MRI上,瘤周水肿预测高位腋窝淋巴结转移的OR为12.3(95%CI:3.9,39.4;P < .001)。
- 标准MRI上,腋窝阳性预测高位腋窝淋巴结转移的OR为5.9(95%CI:2.0,15.2;P < .001)。
- 标准MRI上,腋窝阳性预测晚期腋窝淋巴结转移的OR为8.9(95%CI:3.7,21.5;P < .001)。
- 标准MRI上,瘤周水肿预测晚期腋窝淋巴结转移的OR为2.8(95%CI:1.1,6.9;P = .03)。
- 289例腋窝阴性且无瘤周水肿者中仅3例存在高位腋窝淋巴结转移;310例腋窝阴性且无瘤周水肿者中仅6例存在晚期腋窝淋巴结转移。
诊断标准与关键数值
- 高位腋窝淋巴结转移的预测因素为瘤周水肿(OR=12.3,95%CI:3.9,39.4;P < .001)和腋窝阳性(OR=5.9,95%CI:2.0,15.2;P < .001)。
- 晚期腋窝淋巴结转移的预测因素为腋窝阳性(OR=8.9,95%CI:3.7,21.5;P < .001)和瘤周水肿(OR=2.8,95%CI:1.1,6.9;P = .03)。
临床应用与阅片要点
- 阅片时评估标准MRI是否显示瘤周水肿及腋窝阳性,以判断高位或晚期腋窝淋巴结转移风险。
- 对于瘤周水肿或腋窝阳性的患者,建议加扫全腋窝联合MRI方案以排除高位或晚期转移。
- 腋窝阴性且无瘤周水肿的患者,标准MRI排除高位或晚期转移的表现较满意,可避免不必要的附加扫描。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background In the post-American College of Surgeons Oncology Group Z0011 trial era, radiologists have increasingly focused on excluding high-level or advanced axillary lymph node metastasis (ALNM) by using an additional MRI scan positioned higher than lower axillae; however, the value of these additional scans remains undetermined. Purpose To evaluate whether a standard MRI protocol is sufficient to exclude high-level or advanced ALNM in breast cancer or additional MRI of entire axilla is needed. Materials and Methods This retrospective study evaluated women with invasive breast cancer who underwent breast MRI from April 2015 to December 2016. Some underwent neoadjuvant chemotherapy (NAC) and others underwent upfront surgery. Standard (routine axial scans including the lower axillae) and combined (routine axial scans plus additional scans including the entire axilla) MRI protocols were compared for high-level or advanced ALNM detection. Clinical-pathologic characteristics were analyzed. Uni- and multivariable logistic regression was performed to identify predictors of high-level or advanced ALNM. Results A total of 435 women (mean age ± standard deviation, 52 years ± 11) were evaluated (65 in the NAC group, 370 in the non-NAC group). With the standard MRI protocol, predictors of high-level ALNM were peritumoral edema (odds ratio [OR], 12.3; 95% CI: 3.9, 39.4; P < .001) and positive axilla (OR, 5.9; 95% CI: 2.0, 15.2; P < .001). Only three of 289 women with negative axillae without peritumoral edema had high-level ALNM. Predictors of advanced ALNM were positive axillae (OR, 8.9; 95% CI: 3.7, 21.5; P < .001) and peritumoral edema (OR, 2.8; 95% CI: 1.1, 6.9; P = .03). Only six of 310 women who had negative axillae without peritumoral edema had advanced ALNM. Conclusion The performance of standard MRI was satisfactory in excluding high-level and advanced axillary lymph node metastasis in most patients with breast cancer. However, the presence of peritumoral edema or positive axillae in the MRI findings emphasizes the benefits of a combined MRI protocol. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Abe in this issue.
引用
- Byon JH, Park YV, Yoon JH, et al. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era. Radiology. 2021. PMID: 33904772. doi:10.1148/radiol.2021202683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。